An increasing number of people are infected with antibiotic-resistant bacteria each year, sometimes with fatal consequences. In this manuscript, we report a novel urea-functionalized crown ether that can bind to the bacterial lipid phosphatidylethanolamine (PE), facilitate PE flip-flop and displays antibacterial activity against the Gram-positive bacterium Bacillus cereus with a minimum inhibitory concentration comparable to that of the known PE-targeting lantibiotic duramycin.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/d1ob00263e | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prediction and analysis of toxic and side effects of tigecycline based on deep learning.
Front Microbiol
December 2024
Department of Pharmacy, The Second Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Background: In recent years, with the increase of antibiotic resistance, tigecycline has attracted much attention as a new broad-spectrum glycylcycline antibiotic. It is widely used in the treatment of complex skin and soft tissue infections, complex abdominal infections and hospital-acquired pneumonia by inhibiting bacterial protein synthesis. Tigecycline can exhibit significant time-dependent bactericidal activity, and its efficacy is closely related to pharmacokinetics.
View Article and Find Full Text PDFPreparation and Antibacterial Performance Study of CeO/g-CN Nanocomposite Materials.
Molecules
November 2024
School of Material and Chemical Engineering, Zhengzhou University of Light Industry, 136 Kexue Road, Zhengzhou 450002, China.
In response to the challenges of food spoilage and water pollution caused by pathogenic microorganisms, CeO/g-CN nanocomposites were synthesized via one-step calcination using thiourea and urea as precursors. Steady-state photoluminescence (PL) spectroscopy analysis demonstrated that 8 wt% CeO/g-CN exhibited superior electron-hole separation efficiency. Quantitative antimicrobial assays demonstrated that the nanocomposites displayed enhanced bactericidal activity against , , and .
View Article and Find Full Text PDFPreliminary investigation of the anti- activity of Triphala.
Front Pharmacol
November 2024
School of Medicine and Pharmacy, Ocean University of China, Qingdao, Shandong, China.
Background: Triphala, is a composite of three individual botanical drugs: , , and . It exhibits properties such as heatclearing, anti-inflammatory, anti-fatigue, antioxidant, and antibacterial effects,making it extensively utilized in India and Tibet. It has been found to exhibitinhibitory effects on (); however, further comprehensive research is still needed to elucidate its specific antibacterial mechanism.
View Article and Find Full Text PDFChebulinic acid isolated from aqueous extracts of Retz inhibits infection by potential binding to Cag A protein and regulating adhesion.
Front Microbiol
October 2024
School of Pharmaceutical Sciences, Sun Yat-sen University, Shenzhen, China.
Background: Retz, known as the King of Tibet, is considered a functional food in China, celebrated for its antioxidant, immune-modulating, antibacterial, and anti-inflammatory properties. Chebulinic acid, derived from aqueous extracts of Retz, is known for its anti-inflammatory properties. However, its potential as an anti- (HP) agent has not been fully explored.
View Article and Find Full Text PDFEfficient Production and Purification of Bioactive E50-52-Class IIa Peptidic Bacteriocin Is Achieved through Fusion with the Catalytic Domain of Lysostaphin-Class III Bacteriocin.
Biochemistry (Mosc)
September 2024
Center for Advanced Therapeutics, Institute of Molecular Biosciences, Mahidol University, Nakornpathom, 73170, Thailand.
E50-52, a class IIa-peptidic bacteriocin produced by a strain of , has broad-spectrum antimicrobial activity against various foodborne pathogens. However, effective utilization of the E50-52 has been limited by low production yields and challenges associated with separation and purification of this 39-amino acid antimicrobial peptide. In this study, we have successfully produced a biologically active recombinant form of E50-52 by fusing it with the 16-kDa catalytic domain of lysostaphin-class III bacteriocin (LssCAT), which resulted in high-yield production.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!